[Effect of 5-HT3 receptor antagonists on gastrointestinal motility].
Yoshida
N
N
Ito
T
T
Karasawa
T
T
Iwanaga
H
H
Mizumoto
A
A
Ito
A
A
D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology; D019086:Bridged Bicyclo Compounds, Heterocyclic; D004285:Dogs; D005769:Gastrointestinal Motility / Q000187:drug effects*; D017829:Granisetron; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D007191:Indazoles / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D009037:Motilin / Q000037:antagonists & inhibitors; D017294:Ondansetron; D011817:Rabbits; D012702:Serotonin Antagonists / Q000494:pharmacology*; D000077526:Tropisetron
D001549:Benzamides; D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D017829:Granisetron; D007093:Imidazoles; D007191:Indazoles; D007211:Indoles; D009037:Motilin; D017294:Ondansetron; D012702:Serotonin Antagonists; D000077526:Tropisetron; C053006:renzapride